IP Library Granted Patent US 8,349,566
Granted Patent B2
US 8,349,566 · App. 13/193,390 · Granted Jan 8, 2013

Methods for high level multiplexed polymerase chain reactions and homogenous mass extension reactions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,349,566
App. No.
13/193,390
Granted
Jan 8, 2013
Kind
B2
Abstract

Provided herein are optimized methods for performing multiplexed detection of a plurality of sequence variations. Also provided are methods for performing multiplexed amplification of target nucleic acid.

Claims (25)

1. A multiplex method of genotyping a plurality of polymorphic loci, comprising:

(a) simultaneously amplifying a plurality of nucleic acid-target regions with amplification primer pairs under amplification conditions to produce an amplified mixture of nucleic acid-target regions containing polymorphic loci wherein the amplification conditions comprise dNTPs and for at least one amplification primer pair, one primer is in lower concentration than the other primer;

(b) after (a) contacting the amplified mixture of nucleic acid-target regions with genotyping primers in the presence of at least one chain terminating reagent under primer mass extension conditions whereby the primers are extended up to, or through, the respective polymorphic loci, wherein there is one genotyping primer for each polymorphic locus and wherein the extension conditions comprise at least 55 thermal cycles;

(c) determining the mass of the extended genotyping primers; and

(d) determining the genotypes of the plurality of polymorphic loci from the mass of the extended genotyping primers.

2. The method of claim 1 , wherein a sequence tag is attached to one or more primer pairs.

3. The method of claim 1 , wherein only a single primer pair is utilized to amplify each particular nucleic acid-target region.

4. The method of claim 1 , wherein the amplification-reaction conditions comprise water, genomic DNA, a buffer, dNTPs, the primer pairs, MgCl 2 , and a polymerase, wherein the ratio of the concentration of MgCl 2 to the concentration of each one of the dNTPs is selected from ≦10:1, ≦9:1, ≦8:1, ≦7:1, ≦6:1, or ≦5:1.

5. The method of claim 4 , wherein the polymerase is Taq polymerase at a concentration of 0.03 units/μl.

6. The method of claim 1 , wherein the amplification-reaction conditions comprise between about 400-700 μM of each dNTP, about 100 nM primer pairs, and between about 2.6 up to about 4.8 mM MgCl 2 .

7. The method of claim 1 , wherein a sequence tag is attached to a primer in a primer pair.

8. The method of claim 1 , wherein the extension conditions comprise at least 65 thermal cycles.

9. The method of claim 1 , wherein the extension conditions comprise at least 100 thermal cycles.

10. The method of claim 1 , wherein the concentration of each genotyping primer is selected to even out the mass intensities of the extended genotyping primers.

11. The method of claim 1 , wherein each genotyping primer is selected so that the masses of the extended products and primers do not overlap.

12. The method of claim 1 , further comprising a free Mg 2+ concentration between 1.0-2.0 mM.

13. The method of claim 1 , further comprises inactivating one or more amplification reactants.

14. The method of claim 13 , wherein the one or more amplification reactants includes a nucleotide.

15. The method of claim 14 , wherein the nucleotide is inactivated by a phosphatase.

16. The method of claim 13 , wherein the one or more amplification reactants includes a primer.

17. The method of claim 16 , wherein a primer is inactivated by a nuclease.

18. The method of claim 17 , wherein the nuclease is an exonuclease.

19. The method of claim 1 , wherein for each amplification primer pair, one primer is in lower concentration than the other primer.

20. The method of claim 1 , wherein the lower concentration primer for a particular nucleic acid-target is in the same orientation as the genotyping primer for that nucleic acid-target region.

21. The method of claim 1 , wherein the amplified products of the amplifying step are single-stranded nucleic acid molecules.

Assignments (8)
SECURITY INTEREST Recorded Dec 10, 2021
From: AGENA BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058358/0661 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2021
From: MIDCAP FUNDING IV TRUST
To: AGENA BIOSCIENCE, INC.
Reel/Frame 058741/0005 →
RELEASE OF SECURITY INTEREST IN REEL 041621 FRAME 0548 Recorded Jul 13, 2021
From: MIDCAP FINANCIAL TRUST
To: AGENA BIOSCIENCE, INC.
Reel/Frame 056860/0557 →
SECURITY INTEREST Recorded Mar 21, 2017
From: AGENA BIOSCIENCE, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 042050/0888 →
SECURITY INTEREST Recorded Feb 3, 2017
From: AGENA BIOSCIENCE, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 041621/0548 →
CHANGE OF NAME Recorded Jun 27, 2014
From: BIOSCIENCES ACQUISITION COMPANY
To: AGENA BIOSCIENCE, INC.
Reel/Frame 033248/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2014
From: SEQUENOM, INC.
To: BIOSCIENCES ACQUISITION COMPANY
Reel/Frame 033182/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2011
From: VAN DEN BOOM, DIRK; BEAULIEU, MARTIN
To: SEQUENOM, INC.
Reel/Frame 026697/0439 →